| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | — | — |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $8K | — | -0.8% |
| Operating Income | -$11K | — | -7.0% |
| Interest Expense | $22K | — | -16.8% |
| Net Income | -$3.0M | — | +66.8% |
| EPS (Basic) | -$0.33 | — | — |
| EPS (Diluted) | -$0.33 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27K | +957.1% | +2131.0% |
| Accounts Receivable | $2K | — | — |
| Current Assets | $29K | +1051.5% | +2330.1% |
| Total Assets | $8.3M | -24.2% | +15.8% |
| Current Liabilities | $2.6M | +16.3% | +74.5% |
| Long-term Debt | $927K | -0.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $332K | — | — |
| Investing Cash Flow | -$307K | — | — |
| Financing Cash Flow | $0 | — | — |
| — |
| Total Liabilities | $3.5M | +11.3% | +40.5% |
| Stockholders' Equity | $4.8M | -38.6% | +2.6% |